Pharmafile Logo
Pharmafocus logo
Advanced Search

Vaccine

Showing 15 posts of 283 posts found.

GSK shares new data for RSV vaccine Arexvy

October 25, 2023
Research and Development Arexvy, GSK, Immunology, RSV, Vaccine

GSK announced positive results from its phase 3 trial which assessed the immune response and safety of Arexvy, its respiratory …

News

GSK and Zhifei partner for shingles vaccine promotion in China

October 9, 2023
Medical Communications GSK, Immunology, Shingrix, Vaccine, Zhifei, shingles

GSK has announced that it has come to an exclusive agreement with Chingqing Zhifei Biological Products to co-promote GSK’s shingles …

News

WHO recommends new vaccine for prevention of malaria in children

October 3, 2023
Medical Communications Immunology, Vaccine, WHO, malaria, malaria vaccine

The World Health Organization (WHO) has announced that it has recommended a new vaccine, R21/Matrix-M, for the prevention of malaria …

News
towfiqu-barbhuiya-hn2hqoalbck-unsplash_1

Vaxart shares topline data from phase 2 study of norovirus vaccine candidate

September 8, 2023
Research and Development Infections and infestations, Vaccine, Vaxart, norovirus

Vaxart has announced topline data from its phase 2 challenge study which assessed its oral tablet monovalent norovirus vaccine candidate. …

News

Valneva and Pfizer share positive results from phase 2 trial for Lyme disease vaccine candidate

September 7, 2023
Medical Communications Infections and infestations, Pfizer, Vaccine, Valneva, clinical trial, lyme disease

Valneva and Pfizer have announced positive paediatric and adolescent immunogenicity and safety data for their Lyme disease vaccine candidate, VLA15, …

News

ACM Biolabs shares positive results from phase 1 SARS-CoV-2 booster vaccine trial

September 5, 2023
Research and Development ACM Biolabs, COVID-19, Immunology, SARS-CoV-2, Vaccine, clinical trial

ACM Biolabs has announced positive topline results from its phase 1 trial of ACM-001, an adjuvanted booster vaccine for SARS-CoV-2, …

News

FDA approves Merck’s Ervebo vaccine for under 18s

August 4, 2023
Research and Development FDA, Immunology, Vaccine, ebolavirus

On 3 August 2023, the US Food and Drug Administration (FDA) approved Merck’s Ervebo vaccine for children over 12 months. …

News
vaccinessssssssssssssssssss_1

Bavarian Nordic announces RSV vaccine did not meet all primary endpoints in phase 3 trial

July 25, 2023
Medical Communications Bavarian Nordic, Infections and infestations, RSV, Vaccine, clinical trial

Bavarian Nordic has announced that its phase 3 clinical trial of MVA-BN, its respiratory syncytial virus (RSV) vaccine candidate for …

News
Vaccine image

Pfizer shares new data from phase 2 trial for GBS maternal vaccine candidate

July 20, 2023
Research and Development Immunology, Pfizer, Vaccine, clinical trial

Pfizer has announced new data from its phase 2 study which assessed its hexavalent capsular polysaccharide (CPS) conjugate Group B …

News
1200px-vaccine_image_1_1

FDA approves AstraZeneca’s drug to prevent RSV in babies and young children

July 18, 2023
Research and Development AstraZeneca, FDA, Immunology, RSV, Vaccine, paediatrics

The US Food and Drug Administration (FDA) has announced that it has approved Beyfortus (nirsevimab-alip) for the prevention of respiratory …

News
markus-spiske-dnbtfbnqlrc-unsplash_1

GSK receives FDA Fast Track designation for novel gonorrhoea vaccine

June 27, 2023
Research and Development FDA, GSK, Infections and infestations, Vaccine, fast track designation, gonorrhoea

GSK has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for its investigational vaccine …

News
study_participant_receives_niaid-gsk_candidate_ebola_vaccine

Moderna files for FDA authorisation for updated COVID-19 vaccine

June 23, 2023
Research and Development COVID-19, FDA, Immunology, Moderna, Vaccine

Biotechnology company Moderna has announced that it has completed submission of a regulatory application to the US Food and Drug …

News
mufid-majnun-cm1au42fnrg-unsplash_3

GSK shares positive data for RSV vaccine

June 21, 2023
Research and Development GSK, Immunology, RSV, Vaccine, clinical trial

GSK have announced new positive data from the AReSVi-006 phase 3 trial which assessed the efficacy of a single dose …

News
1200px-vaccine_image_1

GSK’s RSV vaccine approved in EU for older adults

June 7, 2023
Medical Communications EU, GSK, Infections and infestations, RSV, Vaccine

GSK has announced that the European Commission (EC) has authorised Arexvy, the company’s respiratory syncytial virus (RSV) vaccine for active …

News

FDA approves Pfizer’s RSV vaccine for older adults

June 1, 2023
Research and Development FDA, Infections and infestations, Pfizer, RSV, Vaccine

Global pharmaceutical company Pfizer has announced that the US Food and Drug Administration (FDA) has approved its respiratory syncytial virus …

News

Latest content

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024